Home›Companies›Healthcare›Axoft

Axoft, Inc.

Develops brain implants intended to help people with neurological disorders.

Updated Nov 10, 2026·Latest SEC filing May 7, 2026·Suggest an edit

About Axoft

Axoft is a private company based in Cambridge, Massachusetts, incorporated in 2021 in Delaware. It has reported $43,521,356 raised in three offerings on Form D since March 2024. Its chief executive is Paul Le Floch.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 22, 2026May 7, 2026$34,245,380of $34.2M target13$2.6MEquityRule 506(b)Form D ↗
Mar 18, 2022Mar 5, 2024$8,775,976of $9.2M target12$731KEquity, Securities on exerciseRule 506(b)Form D ↗
Feb 20, 2024Mar 5, 2024$500,000of $5.0M target1$500KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, three offerings$43,521,356

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Axoft's Form D filed May 7, 2026.

Paul Le Floch
Paul Le Floch
CEO & Co-Founder, director
CL
Chia An Lee
Director
BP
Benjamin Pless
Director
Also a director at Avertix Medical.

Earlier filings also listed Tianyang Ye (director, last listed Mar 2024) and Rachel Sha (director, last listed Mar 2024).

Sources

  1. SECAXOFT, INC. filing history
  2. CompanyAxoft about